Literature DB >> 6287142

Differentiation between bronchodilation and universal adenosine antagonism among xanthine derivatives.

C G Persson, J A Karlsson, I Erjefält.   

Abstract

Relaxant effects and adenosine-antagonism of 3-propyl-xanthine (enprofylline) and 10 different methyl-xanthines were examined in isolated guinea-pig tracheas. The chemical structural requirements for tracheal relaxation were found to be different from those for adenosine antagonism by the xanthine derivatives. All xanthines produced relaxation: Enprofylline was about 5 times more potent than theophylline. However, only xanthines with a methyl in the 1-position consistently antagonized the relaxant effect of adenosine. --Theophylline over a wide range of concentrations (30-900 microM) produced a concentration dependent and surmountable antagonism at nervous adenosine receptors (isolated guinea-pig myenteric-plexus preparations). The same concentrations of enprofylline were almost devoid of antagonism at these adenosine receptors. In mice theophylline (6-24 mg/kg given intraperitoneally) dose-dependently increased locomotor activity while enprofylline (2-48 mg/Kg) was without effect on behaviour. "Non-blocking" xanthines such as enprofylline may be potent bronchodilators but lack many theophylline-like actions. We, therefore, forward the hypothesis that universal adenosine antagonism is both unnecessary and undesirable with xanthine antiasthmatics.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6287142     DOI: 10.1016/0024-3205(82)90292-2

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  13 in total

1.  Construction of antagonist dose-response curves for estimation of pA2-values by Schild-plot analysis and detection of allosteric interactions.

Authors:  G Pöch; F Brunner; E Kühberger
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

2.  Tracheal relaxation from combinations of xanthines and of a beta 2-receptor agonist and xanthines.

Authors:  C G Persson; B Gustafsson
Journal:  Lung       Date:  1986       Impact factor: 2.584

3.  Reinforcing effects of caffeine and theobromine as found in chocolate.

Authors:  Hendrik J Smit; Rachel J Blackburn
Journal:  Psychopharmacology (Berl)       Date:  2005-10-15       Impact factor: 4.530

4.  Cardiovascular effects of two different xanthines in healthy subjects. Studies at rest, during exercise and in combination with a beta-agonist, terbutaline.

Authors:  T B Conradson
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

5.  Pharmacokinetics of theophylline and enprofylline in patients requiring a high or low dose of theophylline.

Authors:  L C Laursen; N Johannesson; B Weeke
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  Protein binding of enprofylline.

Authors:  K Tegnér; O Borgå; I Svensson
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  Effect of aminophylline on cisplatin nephrotoxicity in the rat.

Authors:  H T Heidemann; S Müller; L Mertins; G Stepan; K Hoffmann; E E Ohnhaus
Journal:  Br J Pharmacol       Date:  1989-06       Impact factor: 8.739

8.  Effects of enprofylline, a xanthine lacking adenosine receptor antagonism, in patients with chronic obstructive lung disease.

Authors:  E Lunell; N Svedmyr; K E Andersson; C G Persson
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

9.  Comparison of oral enprofylline and theophylline in asthmatic patients.

Authors:  L C Laursen; N Johannesson; I Søndergaard; B Weeke
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

10.  Pre- and postjunctional actions of purine and xanthine compounds in the guinea-pig caecum circular muscle.

Authors:  C H Hoyle; I A Vladimirova; G Burnstock
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.